《半日速报》恒指半日收报29,117点 升206点; 恒生科技指数半日收报8,068点 升64点 阿里健康跌逾6% 招行、恒地、交行、同仁堂国药、四环医药创新高
恒指半日收29,117点,升206点或0.7%。恒生科技指数报8,068点,升64点或0.8%。国指升56点或0.5%,报10,849点。
活跃重磅股表现:
美团(03690.HK) 收284.8元,上升3%;
港交所(00388.HK) 收482.2元,上升1.6%;
腾讯(00700.HK) 收618元,上升1.3%;
建行(00939.HK) 收6.33元,上升1.1%;
阿里巴巴(09988.HK) 收208元,上升1%;
平安(02318.HK) 收83.65元,上升0.8%;
友邦(01299.HK) 收101.8元,无升跌;
异动恒指及国指成份股:
阿里健康(00241.HK) 收20.35元,下跌6.9%;
海底捞(06862.HK) 收47.95元,上升4.7%;
中国飞鹤(06186.HK) 收20.95元,下跌4.3%;
银娱(00027.HK) 收65.75元,上升3.4%;
京东健康(06618.HK) 收110元,下跌3.3%;
金沙(01928.HK) 收35.1元,上升3.1%;
招行(03968.HK) 收71.5元,上升1.4%,创新高;
恒地(00012.HK) 收36.4元,上升1.1%,创新高;
交行(03328.HK) 收5.18元,上升0.4%,创新高;
异动综合中小型股:
欧康维视生物-B(01477.HK) 收24.3元,上升11.7%;
远大医药(00512.HK) 收7.5元,上升10.1%;
同仁堂国药(03613.HK) 收12.58元,上升9.4%,创新高;
四环医药(00460.HK) 收3.4元,上升8.6%,创新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.